Mirtazapine
Mirtazapine
- Mirtazapine is generally a prescription-only medicine in most countries (approved by agencies such as the FDA, EMA, MHRA, TGA), though in some local pharmacies it may be possible to obtain it without a receipt or prescription.
- Mirtazapine is used primarily to treat major depressive disorder and for off-label indications such as insomnia, anxiety, and appetite stimulation; it is a tetracyclic (atypical) antidepressant that enhances central noradrenergic and serotonergic neurotransmission by antagonizing presynaptic Ξ±2βadrenergic receptors and blocks 5βHT2/5βHT3 and H1 histamine receptors, which contributes to its sedative and appetite-stimulating effects.
- The usual adult dose for depression is 15β45 mg once daily at bedtime (many patients start at 15 mg; lower starting doses of 7.5β15 mg may be used for insomnia or in elderly/medically vulnerable patients); titrate as needed, with typical therapeutic response within weeks.
- Administered orally as tablets (7.5, 15, 30, 45 mg), orodispersible tablets (15, 30, 45 mg), or occasionally as an oral solution; no injectable or topical formulations for routine use.
- Some sedative effects may be felt within hours of the first dose, and antidepressant effects often begin within 1β2 weeks, with full response commonly taking 4β6 weeks.
- Duration of action covers once-daily dosing (about 24 hours); the elimination half-life is roughly 20β40 hours, supporting once-daily bedtime administration.
- Do not drink alcohol while taking mirtazapine β alcohol increases drowsiness and can worsen CNS depression and impairment of coordination and judgment.
- The most common side effect is somnolence (sedation); other frequent effects include increased appetite/weight gain, dry mouth, dizziness, constipation, and fatigue.
- Would you like to try mirtazapine without a prescription?
Basic Mirtazapine Information
- INN (International Nonproprietary Name): Mirtazapine.
- Brand Names Available In United States: Remeron, Remeron RD (tablets: 7.5, 15, 30, 45 mg).
- ATC Code: N06AX11.
- Forms & Dosages: Tablets 7.5 mg (rare), 15 mg, 30 mg, 45 mg; Orodispersible tablets 15 mg, 30 mg, 45 mg; oral solution (not universally available).
- Manufacturers In United States: Organon, Teva, Sandoz, Sun Pharma, Mylan (global suppliers and regional generics).
- Registration Status In United States: Approved by FDA; marketed under Remeron and generics.
- OTC / Rx Classification: Prescription Only (Rx) in all jurisdictions.
Everyday Use & Best Practices
Morning Vs Evening Dosing
Do you worry whether to take mirtazapine in the morning or at night?
Most people take mirtazapine at bedtime because sedation is a common effect and helps with insomnia.
Taking Remeron tablet or Remeron SolTab in the evening reduces the chance of daytime drowsiness for most patients.
Typical adult dose for major depressive disorder is 15β45 mg once daily at bedtime.
If you notice excessive morning grogginess, discuss switching to an earlier evening dose or lowering the dose with your prescriber.
Taking With Or Without Meals
Mirtazapine can be taken with or without food, and keeping timing consistent versus meals helps produce predictable effects.
If nausea occurs, taking the tablet with a small snack may help reduce stomach upset.
Orodispersible tablets such as Remeron SolTab dissolve on the tongue and do not require water.
Consistency in how you take your mirtazapineβtablet versus orodispersible and relative to mealsβhelps you and your clinician judge effectiveness.
- Practical Tips & Warnings: Always confirm the exact prescription on the label before taking the medicine.
- Keep your pillbox labeled with dose and time to avoid mistakes.
- Avoid alcohol the same day you take mirtazapine because alcohol increases sedation.
- Never stop mirtazapine suddenly without clinician guidance; plan tapering if discontinuing.
| Dose | Common Early Effects |
|---|---|
| 7.5β15 mg | Mild sedation, improved sleep, possible appetite increase |
| 15β30 mg | Stronger sedation at night, gradual mood improvement over weeks |
| 30β45 mg | Full therapeutic dosing for MDD; weight gain risk increases over months |
Safety Priorities
Who Should Avoid It
Who should not take mirtazapine?
Absolute contraindications include concurrent or recent (within 14 days) monoamine oxidase inhibitor use and known hypersensitivity to mirtazapine or any excipient.
Use caution or avoid mirtazapine if you have severe hepatic or renal impairment, a history of bipolar disorder, a seizure disorder, recent myocardial infarction, narrow-angle glaucoma, or urinary retention from prostatic hypertrophy.
Discuss these risks with your prescriber before starting treatment.
Activities To Limit
Avoid driving or operating heavy machinery until you know how mirtazapine affects you because sedation and dizziness are common.
Limit alcohol and other CNS depressants while taking mirtazapine due to additive sedation.
In elderly patients, increased fall risk means a home safety review and consideration of starting at a lower dose is recommended.
- Pre-Treatment Screening Checklist: Current medications (MAOI?), liver/renal disease, seizure history, bipolar history, glaucoma/prostate problems.
- Red Flags Requiring Immediate Medical Attention: severe confusion, rapid heartbeat (tachycardia), seizures, sudden fainting, or signs of allergic reaction.
Dosage & Adjustments
General Regimen
What is a standard mirtazapine regimen?
The standard adult dosing for major depressive disorder is 15β45 mg once daily at bedtime.
Many clinicians start at 15 mg and titrate by response and side effects.
Therapeutic effects may begin in 1β2 weeks, with a full response commonly by 4β6 weeks.
Tablets are commonly available in 7.5 mg (rare), 15 mg, 30 mg, and 45 mg; orodispersible forms are usually 15, 30, and 45 mg.
Special Cases
Elderly patients typically start at a lower dose such as 7.5β15 mg and titrate slowly to reduce risks of sedation and orthostatic hypotension.
In liver impairment, start at the lowest dose and titrate cautiously because active drug levels may increase.
Severe renal impairment calls for close monitoring though mild to moderate impairment often follows adult dosing.
Children and adolescents are not routinely indicated for mirtazapine and require specialist review for off-label use.
| Population | Typical Starting Range | Notes |
|---|---|---|
| Adults (MDD) | 15β45 mg qhs | Start 15 mg, titrate based on response |
| Elderly | 7.5β15 mg qhs | Start low, monitor for falls |
| Liver Impairment | Start lowest available dose | Titrate slowly; monitor adverse effects |
| Renal Impairment | Use with caution | Monitor renal function and side effects |
- Titration Steps Checklist: Start low, reassess at 2β4 weeks, increase slowly if inadequate response, monitor sedation and weight, call prescriber for severe side effects.
User Testimonials
Positive Reports
Many patients report improved sleep early in treatment and reduced nighttime rumination when starting mirtazapine.
Users often mention appetite return and gradual weight gain as helpful when depression caused weight loss.
Orodispersible tabs such as Remeron SolTab receive positive notes for ease of use and reliable night-time sedation when taken at night.
- "Started Remeron 15 mg at bedtime and slept through the night within days."
- "The SolTab is easy on mornings when I forget water."
- "Appetite improved after a couple of weeks, which my oncologist appreciated."
Common Challenges
Common complaints include initial daytime grogginess, weight gain over weeks to months, dry mouth, and vivid dreams.
Some people note mood improvements are gradual and require patience to reach full benefit by 4β6 weeks.
A real-world tip is to keep a symptom diary that tracks sleep, appetite, mood, and side effects for 4β8 weeks to review with the clinician.
- When To Seek Adjustment: excessive sedation, sudden mood shifts, intolerable weight gain, or any new worrying side effect.
Buying Guide
Pharmacy Sources
Mirtazapine is prescription-only in most jurisdictions and should be filled by a licensed pharmacy with a valid prescription.
In the United States, brand-name Remeron and generics from Teva, Sandoz, Sun Pharma, and Mylan are commonly available at local pharmacies and chain drugstores.
Orodispersible forms like Remeron SolTab and equivalents are often stocked separately and may require special ordering at some pharmacies.
In our online pharmacy, mirtazapine is available without a prescription, with discreet delivery to United States in 5-14 days.
Price Comparison
Costs vary by brand, dose, insurance coverage, and pharmacy discounts.
Generics typically reduce cost compared with Remeron brand products.
Consider manufacturer coupons, pharmacy discount plans, and mail-order 90-day fills for savings.
| Product | Form | Typical Cost Range |
|---|---|---|
| Remeron | Tablets 15β45 mg | Higher (brand pricing varies) |
| Generic Mirtazapine (Teva/Sandoz/Mylan) | Tablets/Orodispersible | Lower (varies by pharmacy) |
| Remeron SolTab | Orodispersible 15β45 mg | Moderate to higher (sometimes limited supply) |
- Safe Online Pharmacy Checklist: verify state pharmacy license, check NABP/VIPPS listings or valid accreditation, require valid prescription, read customer reviews and privacy policy.
Whatβs Inside & How It Works
Ingredients Overview
The active ingredient is mirtazapine (INN).
Formulations include standard tablets and orally disintegrating tablets in 15, 30, and 45 mg strengths, with rare 7.5 mg tablets and occasional oral solutions.
Excipients vary by manufacturer, so check the product leaflet if you have known excipient allergies.
Common manufacturers include Organon, Teva, Sandoz, HEXAL, ratiopharm, Sun Pharma, and Mylan.
Mechanism Basics
Mirtazapine is classified under ATC code N06AX11 as a tetracyclic "other antidepressant."
It increases noradrenergic and serotonergic neurotransmission mainly by antagonizing central presynaptic alpha-2 receptors and blocking certain serotonin receptors.
This mechanism contributes to antidepressant effects while producing distinct side effects such as sedation and increased appetite.
| Mechanism | Common Clinical Effect |
|---|---|
| Alpha-2 Antagonism | Increased noradrenergic and serotonergic release |
| 5-HT2/5-HT3 Blockade | Improved sleep, fewer nausea symptoms, lower sexual side effects |
| H1 Antagonism | Sedation and increased appetite |
Main Indications
Approved Uses
Mirtazapine's primary approved indication is major depressive disorder in adults.
Regulatory approval exists from agencies including the FDA in the United States, EMA in Europe, MHRA in the UK, and TGA in Australia.
Recommended adult dose range for MDD is 15β45 mg once daily, usually at bedtime.
Off-Label Uses
Common off-label uses include treatment of insomnia related to depression, appetite stimulation in oncology or palliative care, management of anxiety comorbid with MDD, and selective use for nausea in specific settings.
Off-label dosing often starts lower (7.5β15 mg at bedtime) and should be under specialist oversight when used outside approved indications.
| Indication | Typical Starting Dose | Monitoring Notes |
|---|---|---|
| Major Depressive Disorder (Approved) | 15 mg qhs | Assess mood at 2β4 weeks; titrate to effect |
| Insomnia With Depression (Off-Label) | 7.5β15 mg qhs | Monitor daytime sedation |
| Appetite Stimulation (Off-Label) | 7.5β15 mg qhs | Monitor weight and metabolic changes |
Interaction Warnings
Food Interactions
There are no major food restrictions for mirtazapine, but maintaining consistency in timing of doses versus meals helps predictable effects.
Avoid alcohol while taking mirtazapine because it increases sedation and slows reaction time.
Grapefruit is not a classic interaction for mirtazapine, but check product-specific labels for excipient warnings.
Drug Conflicts
Concurrent use with MAOIs is an absolute contraindication; avoid starting mirtazapine within 14 days of stopping an MAOI.
Be cautious combining mirtazapine with other CNS depressants and with multiple serotonergic drugs due to serotonin syndrome risk.
Monitor use with drugs that lower seizure threshold and with antihypertensives because mirtazapine can cause orthostatic hypotension.
- High-Risk Drug Classes: MAOIs, other antidepressants with strong serotonergic action, benzodiazepines or opioids (CNS depressants), anticholinergic agents that compound urinary retention.
- Medication Reconciliation Checklist: list all prescriptions, OTCs, supplements, and recent MAOI use before starting mirtazapine.
Latest Evidence & Insights
Key Trials
Systematic reviews and randomized trials confirm mirtazapine's efficacy in major depressive disorder with faster improvements in sleep and appetite compared with some SSRIs.
Comparative trials generally show similar antidepressant efficacy to SSRIs and SNRIs but with a distinct side-effect profile: more sedation and weight gain, and fewer sexual side effects.
Practical Takeaways
Use mirtazapine when insomnia or poor appetite are prominent depressive symptoms, and consider alternate agents if daytime sedation or weight gain are unacceptable.
Evidence supports cautious use in elderly patients with dose reduction and monitoring for falls.
| Study/Review | Population | Outcome |
|---|---|---|
| Systematic Reviews (Multiple RCTs) | Adults With MDD | Effective antidepressant; faster sleep improvements vs some SSRIs |
| Head-to-Head Trials | Comparative Antidepressants | Similar mood efficacy; different side-effect profile |
- Clinical Takeaway Checklist: consider mirtazapine for MDD with insomnia or weight loss, start low in elderly, reassess by 4β6 weeks, monitor weight and sedation.
Alternative Choices
Comparisons
Alternatives to mirtazapine include SSRIs such as sertraline, escitalopram, and fluoxetine.
SNRIs like venlafaxine and duloxetine and other atypicals such as trazodone or bupropion are also options depending on symptom profile.
Compared with SSRIs, mirtazapine often causes more sedation and weight gain but fewer sexual side effects and faster sleep benefits.
When To Switch
Consider switching if there is inadequate mood response after 4β6 weeks at therapeutic doses or if side effects are intolerable, such as severe daytime sedation or marked weight gain.
Plan washout timing carefully depending on the agents involved; do not overlap with MAOIs within 14 days.
| Agent | Side-Effect Profile | Onset Speed |
|---|---|---|
| Mirtazapine | More sedation, weight gain; fewer sexual AEs | Sleep improves early; mood by 4β6 weeks |
| SSRI (e.g., Sertraline) | Less sedation, possible sexual side effects | Mood improvement by 4β6 weeks |
| Bupropion | Less sexual dysfunction, activating | Variable onset; useful if sedation unacceptable |
- Switch Steps Checklist: confirm treatment failure or intolerance, check washout windows (MAOI 14 days), consider cross-titration or direct switch per prescriber guidance, monitor closely during transition.
Regulation Snapshot
Approval Status
Mirtazapine is approved by major regulators including the FDA in the United States, EMA in Europe, MHRA in the UK, and TGA in Australia.
It is marketed under Remeron, Zispin, Avanza, and many generics worldwide.
It is prescription-only internationally and listed in national registries in many countries.
Prescription Rules
Mirtazapine requires a clinician prescription and is not available over the counter.
Special caution and documentation are advised when prescribing off-label uses, especially in children and adolescents where specialist oversight is recommended.
Reporting adverse events to local pharmacovigilance agencies is important for post-marketing safety monitoring.
| Regulatory Agency | Approval Note |
|---|---|
| FDA (United States) | Approved for MDD; prescription-only |
| EMA (Europe) | Approved; marketed under multiple brands |
| TGA (Australia) | Approved as Avanza and generics |
- Prescriber Checklist: document indication, consent for off-label use, baseline weight and blood pressure, review concomitant medications, plan follow-up schedule.
FAQ Section
Quick Answers
Will it make me sleepy?
Often yesβmirtazapine commonly causes sleepiness and is therefore best taken at bedtime.
How long to see effect?
Sleep and appetite changes may appear in 1β2 weeks; mood improvement often takes 4β6 weeks.
Is it addictive?
It is not classically addictive, but abrupt stopping can cause discontinuation symptoms so tapering is recommended.
When To Call Doctor
Contact your prescriber immediately for worsening mood or suicidal thoughts, severe dizziness or fainting, signs of infection or unusual bleeding, jaundice, seizures, or allergic reactions.
Arrange a medication review for persistent intolerable side effects such as excessive sedation or significant weight gain.
- Emergency Red-Flag Checklist: suicidal ideation, severe allergic reaction, seizure, sudden severe palpitations, shortness of breath, or yellowing of the skin/eyes.
Guidelines For Proper Use
Tapering And Discontinuation
Gradual taper is recommended to minimize withdrawal symptoms, typically with stepwise dose reductions over weeks under clinician supervision.
Abrupt cessation can cause dizziness, insomnia, irritability, or flu-like symptoms.
If switching classes, follow recommended washout windows; avoid MAOI overlap and allow 14 days between stopping an MAOI and starting mirtazapine.
Monitoring And Follow-Up
Follow-up at 2β4 weeks initially to assess response and side effects, then periodically every 4β12 weeks once stable.
Monitor weight, blood pressure including orthostatic checks, and inquire about sedation, sexual function, and mood changes at each visit.
Consider a complete blood count if clinical concerns arise because rare blood dyscrasias have been reported.
- Monitoring Checklist For Patients And Clinicians: baseline weight and BP, follow-up appointment 2β4 weeks, monthly weight checks for first three months, report new seizures or psychiatric worsening promptly.
| Sample Taper Template | Example Schedule |
|---|---|
| From 30 mg | Reduce to 15 mg for 1β2 weeks, then 7.5 mg for 1β2 weeks, then stop under supervision |
| From 15 mg | Reduce to 7.5 mg for 1β2 weeks, then stop if tolerated |
Delivery Across United States
| City | Region | Delivery Time |
|---|---|---|
| New York | Northeast | 5-7 days |
| Los Angeles | West | 5-7 days |
| Chicago | Midwest | 5-7 days |
| Houston | South | 5-7 days |
| Phoenix | West | 5-7 days |
| Philadelphia | Northeast | 5-7 days |
| San Antonio | South | 5-7 days |
| San Diego | West | 5-7 days |
| Dallas | South | 5-7 days |
| San Jose | West | 5-7 days |
| Austin | South | 5-9 days |
| Jacksonville | Southeast | 5-9 days |
| Fort Worth | South | 5-9 days |
| Columbus | Midwest | 5-9 days |
| Charlotte | Southeast | 5-9 days |
Final Notes
When considering mirtazapine, discuss your full medical history and current medications with your prescriber to ensure safety and appropriate selection of dose and formulation.
Keep a medication log and symptom diary during the first 4β8 weeks to help your clinician optimize therapy.
If you have questions about sourcing Remeron 15 mg or a Remeron SolTab formulation, your pharmacist can check availability and manufacturer options such as Teva, Sandoz, Sun Pharma, and Mylan.
Remember that therapeutic improvements often require weeks, and follow-up at 2β4 weeks is important to review response and side effects.